Trupanion's estimated economic combined ratio improved to 98.5% in H1 2026, extending the underwriting profitability first achieved in 2025. Operating leverage and lower acquisition costs drove much of the improvement, while the H1 loss ratio also declined to 71.0% from 72.1%. Management's 2026 guidance could imply $32–$40 million of net income, providing stronger evidence that scale is finally translating into profitability.
Trupanion's Q2 earnings beat estimates as revenue rose 11%, while premium valuation and muted analyst sentiment support a wait-and-see approach.
Trupanion, Inc. (TRUP) Q2 2026 Earnings Call Transcript
Trupanion NASDAQ: TRUP reported higher second-quarter revenue and adjusted operating income as the pet insurer benefited from increased subscription revenue, improved enrollment conversion and stable retention. The company also announced a $100 million share repurchase authorization and narrowed its full-year adjusted operating income outlook.
While the top- and bottom-line numbers for Trupanion (TRUP) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Trupanion (TRUP) came out with quarterly earnings of $0.16 per share, beating the Zacks Consensus Estimate of $0.11 per share. This compares to earnings of $0.22 per share a year ago.
Trupanion (TRUP) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
The average of price targets set by Wall Street analysts indicates a potential upside of 46.3% in Trupanion (TRUP). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Trupanion (TRUP) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Trupanion TodayTRUPTrupanion$23.57 +0.32 (+1.38%) As of 04:00 PM Eastern52-Week Range$21.16▼$57.88P/E Ratio39.95Price Target$42.25Add to WatchlistTrupanion NASDAQ: TRUP has spent years telling investors a compelling story about pet insurance. Yet despite steadily rising revenue over the years, Trupanion has struggled to translate that growth into profits.
Trupanion TodayTRUPTrupanion$23.64 +0.08 (+0.32%) As of 12:25 PM Eastern This is a fair market value price provided by Massive. Learn more.52-Week Range$21.16▼$57.88P/E Ratio40.08Price Target$42.25Add to WatchlistTrupanion NASDAQ: TRUP has spent years telling investors a compelling story about pet insurance.
Investors need to pay close attention to TRUP stock based on the movements in the options market lately.